The Food and Drug Administration approves Actonel (risedronate sodium) for the treatment of osteoporosis in men.
Its manufacturers, Proctor and Gamble Pharmaceuticals and Sanofi-Aventis, say the drug is already commonly prescribed for the soft-bones condition in post-menopausal women
